1. Home
  2. EVO vs UCTT Comparison

EVO vs UCTT Comparison

Compare EVO & UCTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • UCTT
  • Stock Information
  • Founded
  • EVO 1993
  • UCTT 1991
  • Country
  • EVO Germany
  • UCTT United States
  • Employees
  • EVO N/A
  • UCTT N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • UCTT Semiconductors
  • Sector
  • EVO Health Care
  • UCTT Technology
  • Exchange
  • EVO Nasdaq
  • UCTT Nasdaq
  • Market Cap
  • EVO 1.2B
  • UCTT 1.1B
  • IPO Year
  • EVO 2021
  • UCTT 2004
  • Fundamental
  • Price
  • EVO $3.73
  • UCTT $28.26
  • Analyst Decision
  • EVO Buy
  • UCTT Strong Buy
  • Analyst Count
  • EVO 2
  • UCTT 3
  • Target Price
  • EVO $5.40
  • UCTT $39.00
  • AVG Volume (30 Days)
  • EVO 41.5K
  • UCTT 307.1K
  • Earning Date
  • EVO 11-05-2025
  • UCTT 10-27-2025
  • Dividend Yield
  • EVO N/A
  • UCTT N/A
  • EPS Growth
  • EVO N/A
  • UCTT N/A
  • EPS
  • EVO N/A
  • UCTT N/A
  • Revenue
  • EVO $912,894,891.00
  • UCTT $2,141,100,000.00
  • Revenue This Year
  • EVO $0.39
  • UCTT N/A
  • Revenue Next Year
  • EVO $9.53
  • UCTT $4.45
  • P/E Ratio
  • EVO N/A
  • UCTT N/A
  • Revenue Growth
  • EVO N/A
  • UCTT 14.28
  • 52 Week Low
  • EVO $2.84
  • UCTT $16.66
  • 52 Week High
  • EVO $5.64
  • UCTT $41.90
  • Technical
  • Relative Strength Index (RSI)
  • EVO 57.04
  • UCTT 73.46
  • Support Level
  • EVO $3.43
  • UCTT $25.51
  • Resistance Level
  • EVO $3.55
  • UCTT $25.82
  • Average True Range (ATR)
  • EVO 0.08
  • UCTT 0.92
  • MACD
  • EVO 0.05
  • UCTT 0.33
  • Stochastic Oscillator
  • EVO 90.27
  • UCTT 95.17

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.

Share on Social Networks: